![Jacques Mallet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jacques Mallet
Voorzitter bij
VALERIO THERAPEUTICS
Profiel
Jacques Mallet currently works at Valerio Therapeutics SA, as Chairman, Gamma-X Corporate Advisory, as Chairman, Evolva SA, as Director-Executive Board from 2009, NEUWAY Pharma GmbH, as Director, and Fournier-Majoie Foundation, as Director.
Dr. Mallet also formerly worked at Theraptosis SA, as Director-Supervisory Board, AlchiMedics SA, as Director, EvoNext Holdings SA, as Director, Isocell Nutra SAS, as Director, Auriga Partners SA, as Partner from 2010 to 2012, Technoflex SAS, as Member-Supervisory Board, and Sanofi, as VP-Portfolio Analytics & Corporate Strategy.
Actieve functies van Jacques Mallet
| Bedrijven | Functie | Begin |
|---|---|---|
| VALERIO THERAPEUTICS | Voorzitter | - |
Evolva SA
 Evolva SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company focused on the research, development and commercialization of ingredients based on nature | Corporate Officer/Principal | 18-11-2009 |
Fournier-Majoie Foundation | Directeur/Bestuurslid | - |
NEUWAY Pharma GmbH
 NEUWAY Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops treatments for central nervous system diseases | Directeur/Bestuurslid | - |
Eerdere bekende functies van Jacques Mallet
| Bedrijven | Functie | Einde |
|---|---|---|
Auriga Partners SA
 Auriga Partners SA Investment ManagersFinance Auriga Partners invests in small and mid sized companies located in France and Europe. The firm targets companies operating in the fields of IT and life science sectors. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 1 - 5 million and also take minority stakes. | Directeur/Bestuurslid | 31-12-2012 |
Theraptosis SA
 Theraptosis SA Pharmaceuticals: MajorHealth Technology Develops and manufactures various drugs for cancer and neurodegenerative diseases | Directeur/Bestuurslid | 10-03-2010 |
| SANOFI | Corporate Officer/Principal | - |
Isocell SA
 Isocell SA Food RetailRetail Trade Perates as a holding company with interests in the manufacture and sale of food supplements | Directeur/Bestuurslid | - |
| TECHNOFLEX | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
25
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Auriga Partners SA
Auriga Partners SA Investment ManagersFinance Auriga Partners invests in small and mid sized companies located in France and Europe. The firm targets companies operating in the fields of IT and life science sectors. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 1 - 5 million and also take minority stakes. | Finance |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Technoflex SAS
 Technoflex SAS Chemicals: Major DiversifiedProcess Industries Designs and produces flexible bags & components for injectable solutions | Process Industries |
Theraptosis SA
Theraptosis SA Pharmaceuticals: MajorHealth Technology Develops and manufactures various drugs for cancer and neurodegenerative diseases | Health Technology |
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company focused on the research, development and commercialization of ingredients based on nature | Commercial Services |
AlchiMedics SA
 AlchiMedics SA Chemicals: Major DiversifiedProcess Industries Specializes in electro grafting coating technologies | Process Industries |
Evolva Holding SA
 Evolva Holding SA Food: Specialty/CandyConsumer Non-Durables Develops and sells flavors, fragrances and health ingredients | Consumer Non-Durables |
Isocell SA
Isocell SA Food RetailRetail Trade Perates as a holding company with interests in the manufacture and sale of food supplements | Retail Trade |
NEUWAY Pharma GmbH
NEUWAY Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops treatments for central nervous system diseases | Health Technology |
Fournier-Majoie Foundation |
